Intero Biosystems Wins Startup Battlefield 2026
Denver-based Intero Biosystems has been named the winner of the TechCrunch Startup Battlefield 2026, showcasing its lab-grown intestinal tissue technology.

Denver-based Intero Biosystems has been named the winner of the TechCrunch Startup Battlefield 2026, showcasing its lab-grown intestinal tissue technology.

Google has launched the Antigravity platform, an AI-driven tool that accelerates the discovery of antimicrobial peptides by integrating database screening and structural analysis.

OpenAI is offering US university biology labs sponsored access to its GPT-Rosalind model, including up to 30 free seats and data privacy protections for academic research.

Catalio Capital Management is raising $500 million to invest in startups combining artificial intelligence with healthcare and biomedicine.

AI-powered drug discovery startup Iambic Therapeutics raised $150 million in its Nasdaq IPO, with shares climbing 16% to $18.50 on the first day of trading.

Global venture capital markets saw over $1.51 billion in funding for 10 startups, with a focus on AI infrastructure, biotechnology, and enterprise software.

AstraZeneca and insitro have formed an AI-focused partnership to develop treatments for heart and liver diseases in a deal potentially worth up to $1.5 billion.

Milan-based Panakès Partners has launched an €8.5 million investment vehicle to support MedTech and BioTech startups in the Lombardy region.

Nine UK life sciences companies visited Shanghai to explore R&D partnerships, clinical trials, and investment opportunities with local Chinese firms.

Science Corporation has implanted its Prima chip in a patient with Stargardt disease, marking a step toward restoring vision for those with incurable retinal conditions.

Colossal Biosciences has introduced the GenoMorph AI platform to identify gene-editing targets for de-extinction projects, starting with the dodo.

Colossal Biosciences has launched an AI platform called GenoMorph to identify genetic targets for de-extinction projects, starting with the dodo bird.

Quantum Computing Inc. and INmune Bio have partnered to use quantum optimization to identify new therapeutic applications for the experimental Alzheimer’s drug XPro.

Researchers from the University of Washington used AI tools to design synthetic enzymes that can target and cut specific proteins linked to neurological diseases.

Zealand Pharma has partnered with Generate Biomedicines in a deal worth up to $1.2 billion to leverage AI for developing new obesity treatments.

Mining tech startup Giraffe Bio raised $6.4 million to scale its biotechnology platform, which helps mines increase copper recovery by up to 5% using bespoke biomolecules.

Undecimal Bio has raised €16 million in seed funding to advance its AI-powered platform for targeted RNA therapeutics beyond the liver.

A COVID-19 vaccine trial led by PopVax is being funded by $20 million from the Gates Foundation and Vitalik Buterin’s Balvi fund, which relies on proceeds from unsolicited Shiba Inu tokens.

NASA and SpaceX are launching the CRS-35 resupply mission to the International Space Station, carrying four key biological and physical science experiments to support future long-duration space travel.

Ultrahuman has partnered with Abu Dhabi health authorities to develop a national-scale biological-age model that integrates wearable data with clinical biomarkers.